| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.006 |